NOTCH1 and neoplasm: As a sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) modulator, thapsigargin may inhibit oncogenic NOTCH 1 signaling (Pagliaro et al., 2021), thereby possibly suppressing tumor growth.